Difference between revisions of "Team:DTU-Denmark/achievements"

Line 119: Line 119:
 
             <h3 class="h3">Bronze</h3>
 
             <h3 class="h3">Bronze</h3>
 
              
 
              
            <div class="grid-row">
 
                <div class="col-md-3 col-sm-3 col-xs-12">
 
                    <p style="text-align:left;"><span class="check">&#10003;</span> Tryout blblblblblb</p>
 
                </div>
 
                <div class="col-md-9 col-sm-9 col-xs-12">
 
                    <p>We <a href="https://igem.org/Team.cgi?team_id=2117">registered</a> for iGEM, have a great summer, and attend the Giant Jamboree.</p>
 
                </div>
 
            </div> <!-- /grid-row -->
 
 
              
 
              
 
              
 
              
Line 134: Line 126:
 
                 </div>
 
                 </div>
 
                 <div class="col-md-9 col-sm-9 col-xs-12">
 
                 <div class="col-md-9 col-sm-9 col-xs-12">
                     <p>We <a href="https://igem.org/Team.cgi?team_id=2117">registered</a> for iGEM, have a great summer, and attend the Giant Jamboree.</p>
+
                     <p>We registred for iGEM, had great and educational (sometimes frustrating) summer. We also attended the Giant jamboree. </p>
 
                 </div>
 
                 </div>
 
             </div> <!-- /grid-row -->
 
             </div> <!-- /grid-row -->
Line 142: Line 134:
 
                 </div>
 
                 </div>
 
                 <div class="col-md-9 col-sm-9 col-xs-12">
 
                 <div class="col-md-9 col-sm-9 col-xs-12">
                     <p>Meet all deliverables on the Requirements page (section 3).</p>
+
                     <p>Yes, we met all the deliverables. Take a look around on our awesome wiki. We have registered and submitted all our parts. We have filled out the safety, judging and registry forms as required. The team is ready with the presentation and poster for the Giant Jamboree.</p>
 
                 </div>
 
                 </div>
 
             </div> <!-- /grid-row -->
 
             </div> <!-- /grid-row -->
Line 150: Line 142:
 
                 </div>
 
                 </div>
 
                 <div class="col-md-9 col-sm-9 col-xs-12">
 
                 <div class="col-md-9 col-sm-9 col-xs-12">
                     <p>Create a page on your team wiki with clear attribution of each aspect of your project. This page must clearly attribute work done by the students and distinguish it from work done by others, including host labs, advisors, instructors, sponsors, professional website designers, artists, and commercial services.</p>
+
                     <p>Even though this project was driven and conducted by the team only, we have gotten a lot of much appreciated help during this project. Everyone should of course be credited for their attributions. Please see our  <a href="https://2016.igem.org/Team:DTU-Denmark/Attributions">attribution site</a> </p>
 
                 </div>
 
                 </div>
 
             </div> <!-- /grid-row -->
 
             </div> <!-- /grid-row -->
Line 158: Line 150:
 
                 </div>
 
                 </div>
 
                 <div class="col-md-9 col-sm-9 col-xs-12">
 
                 <div class="col-md-9 col-sm-9 col-xs-12">
                     <p>Document at least one new standard BioBrick Part or Device central to your project and submit this part to the iGEM Registry (submissions must adhere to the iGEM Registry guidelines). You may also document a new application of a BioBrick part from a previous iGEM year, adding that documentation to the part main page.</p>
+
                     <p>We have registered and submitted our new part BBa_K2117003. This part encodes the Human Proinsulin peptide. The gene has been codon-optimized for the yeast <i>Yarrowia lipolytica</i> using a DTU-Denmark iGEM 2016 team designed <a href="https://2016.igem.org/Team:DTU-Denmark/Software">codon-optimization tool</a> that also considers illegal restriction sites.</p>
 
                 </div>
 
                 </div>
 
             </div> <!-- /grid-row -->
 
             </div> <!-- /grid-row -->
Line 170: Line 162:
 
                 </div>
 
                 </div>
 
                 <div class="col-md-9 col-sm-9 col-xs-12">
 
                 <div class="col-md-9 col-sm-9 col-xs-12">
                     <p>Experimentally validate that at least one new BioBrick Part or Device of your own design and construction works as expected. Document the characterization of this part in the Main Page section of that Part’s/Device’s Registry entry. Submit this new part to the iGEM Parts Registry. This working part must be different from the part documented in bronze medal criterion #4.</p>
+
                     <p>Our new BioBrick device <a href="http://parts.igem.org/Part:BBa_K2117004">BBa_K2117004</a> encodes the humanized Renilla reniformis green fluorescent protein (hrGFP) codon-optimized for <i>Yarrowia lipolytica</i> and the translation elongation factor-1α (TEF1) promoter. We have used this device to demonstrate heterologous protein expression in <i>Y. lipolytica</i> and experimentally validated it through confocal laser scanning microscope. </p>
 
                 </div>
 
                 </div>
 
             </div> <!-- /grid-row -->
 
             </div> <!-- /grid-row -->
Line 178: Line 170:
 
                 </div>
 
                 </div>
 
                 <div class="col-md-9 col-sm-9 col-xs-12">
 
                 <div class="col-md-9 col-sm-9 col-xs-12">
                     <p>Convince the judges you have helped any registered iGEM team from high school, a different track, another university, or another institution in a significant way by, for example, mentoring a new team, characterizing a part, debugging a construct, modeling/simulating their system or helping validate a software/hardware solution to a synbio problem.</p>
+
                     <p>We have helped different iGEM teams during summer: Uppsala iGEM, UNIK-cph, SDU-Denmark. For more information please see <a href="https://2016.igem.org/Team:DTU-Denmark/Collaborations">collaborations.</a></p>
 
                 </div>
 
                 </div>
 
             </div> <!-- /grid-row -->
 
             </div> <!-- /grid-row -->
Line 186: Line 178:
 
                 </div>
 
                 </div>
 
                 <div class="col-md-9 col-sm-9 col-xs-12">
 
                 <div class="col-md-9 col-sm-9 col-xs-12">
                     <p>iGEM projects involve important questions beyond the lab bench, for example relating to (but not limited to) ethics, sustainability, social justice, safety, security, and intellectual property rights. Demonstrate how your team has identified, investigated, and addressed one or more of these issues in the context of your project. Your activity could center around education, public engagement, public policy issues, public perception, or other activities (see the human practices hub for more information and examples of previous teams' exemplary work).</p>
+
                     <p>We sure went beyond the lab bench during this project. Our biggest achievement was the launch of the <a href="https://2016.igem.org/Team:DTU-Denmark/Engagement">Biosensor project</a>, a platform for allowing over 200 high schools nationwide. We also held meet-ups for other iGEM teams, presented our project at different events and got media coverage. Please see our             
 +
                    <a href="https://2016.igem.org/Team:DTU-Denmark/HP/Silver">practices page</a> for elaboration.</p>
 
                 </div>
 
                 </div>
 
             </div> <!-- /grid-row -->
 
             </div> <!-- /grid-row -->
Line 198: Line 191:
 
                 </div>
 
                 </div>
 
                 <div class="col-md-9 col-sm-9 col-xs-12">
 
                 <div class="col-md-9 col-sm-9 col-xs-12">
                     <p>Expand on your silver medal activity by demonstrating how you have integrated the investigated issues into the design and/or execution of your project.</p>
+
                     <p>Throughout our project we have been in close contact and collaboration with the industry. We started out searching for abundant waste streams in Denmark by contacting and visiting local factories, then we presented our idea to biotech manufacturing companies and all together the feedback made us more aware of the challenges our technology is facing and it ultimately led us to a more feasible product. Please see (link)</p>
 
                 </div>
 
                 </div>
 
             </div> <!-- /grid-row -->
 
             </div> <!-- /grid-row -->
Line 206: Line 199:
 
                 </div>
 
                 </div>
 
                 <div class="col-md-9 col-sm-9 col-xs-12">
 
                 <div class="col-md-9 col-sm-9 col-xs-12">
                     <p>Improve the function OR characterization of an existing BioBrick Part or Device and enter this information in the Registry. Please see the Registry help page on how to document a contribution to an existing part. This part must NOT be from your 2016 part number range.</p>
+
                     <p>We have improved the two BioBricks; BBa_K530001 (CrtE gene) and BBa_K530002 (CrtI gene) created by the John Hopkins iGEM team 2011. We used site directed mutagenesis to successfully remove of two illegal restriction sites and further improved the characterization. Please see the <a href="https://2016.igem.org/Team:DTU-Denmark/Description">parts page</a> for elaboration.</p>
 
                 </div>
 
                 </div>
 
             </div> <!-- /grid-row -->
 
             </div> <!-- /grid-row -->
Line 214: Line 207:
 
                 </div>
 
                 </div>
 
                 <div class="col-md-9 col-sm-9 col-xs-12">
 
                 <div class="col-md-9 col-sm-9 col-xs-12">
                     <p>Demonstrate a functional proof of concept of your project. Your proof of concept must consist of a BioBrick device; a single BioBrick part cannot constitute a proof of concept. (biological materials may not be taken outside the lab).</p>
+
                     <p>We successfully designed a functional plasmid (pSBB1A8YL) for transformation and replication in both E. coli and Y. lipolytica. pSBB1A8YL is also compatible with the BioBrick standard by assembly with our own BioBrick device <a href="http://parts.igem.org/Part:BBa_K2117005">BBa_K2117005</a>. Further we showed that we could utilize the construct in Y. lipolytica to express a heterologous protein, hrGFP. Please see the <a href="https://2016.igem.org/Team:DTU-Denmark/Proof">proof of concept page</a> for elaboration.</p>
 
                 </div>
 
                 </div>
 
             </div> <!-- /grid-row -->
 
             </div> <!-- /grid-row -->
Line 222: Line 215:
 
                 </div>
 
                 </div>
 
                 <div class="col-md-9 col-sm-9 col-xs-12">
 
                 <div class="col-md-9 col-sm-9 col-xs-12">
                     <p>Show your project working under real-world conditions. To achieve this criterion, you should demonstrate your whole system, or a functional proof of concept working under simulated conditions in the lab (biological materials may not be taken outside the lab).</p>
+
                     <p></p>
 
                 </div>
 
                 </div>
 
             </div> <!-- /grid-row -->
 
             </div> <!-- /grid-row -->
         </div>
+
         </div>  
 
          
 
          
 
          
 
          

Revision as of 12:48, 19 October 2016

New HTML template for the wiki




Bootstrap Example

Title

leader under the title, short introduction. Ubique moderatius efficiantur eum et, dico oporteat recusabo ius cu, pro id modus sadipscing. Maluisset patrioque eum ad, mel eius doctus accommodare eu, minimum deleniti repudiandae mel ea. Noster nostrud diceret sea no. Eos an nullam molestiae signiferumque, vel ne laudem ignota oblique. Duo te luptatum percipitur signiferumque, at dicunt iriure dolorem his.


Milestones

Quote Lorem ipsum dolor sit amet, consectetur adipiscing elit. Integer posuere erat a ante.

Someone famous in Source Title

Etiam sit amet orci eget

Quisque rutrum. Aenean imperdiet. Etiam ultricies nisi vel augue. Curabitur ullamcorper ultricies nisi. Nam eget dui. Etiam rhoncus.

Aenean imperdiet - (90mins)

Etiam sit amet orci eget

Quisque rutrum. Aenean imperdiet. Etiam ultricies nisi vel augue. Curabitur ullamcorper ultricies nisi. Nam eget dui. Etiam rhoncus.

Aenean imperdiet - (~45mins)

Etiam sit amet orci eget

Quisque rutrum. Aenean imperdiet. Etiam ultricies nisi vel augue. Curabitur ullamcorper ultricies nisi. Nam eget dui. Etiam rhoncus.

Aenean imperdiet - (~30mins)

Etiam sit amet orci eget

Quisque rutrum. Aenean imperdiet. Etiam ultricies nisi vel augue. Curabitur ullamcorper ultricies nisi. Nam eget dui. Etiam rhoncus.

Aenean imperdiet - (~45mins)

Medal Requirements

Bronze

Register and attend

We registred for iGEM, had great and educational (sometimes frustrating) summer. We also attended the Giant jamboree.

Deliverables

Yes, we met all the deliverables. Take a look around on our awesome wiki. We have registered and submitted all our parts. We have filled out the safety, judging and registry forms as required. The team is ready with the presentation and poster for the Giant Jamboree.

Attribution

Even though this project was driven and conducted by the team only, we have gotten a lot of much appreciated help during this project. Everyone should of course be credited for their attributions. Please see our attribution site

Part

We have registered and submitted our new part BBa_K2117003. This part encodes the Human Proinsulin peptide. The gene has been codon-optimized for the yeast Yarrowia lipolytica using a DTU-Denmark iGEM 2016 team designed codon-optimization tool that also considers illegal restriction sites.

Silver

Validated Part

Our new BioBrick device BBa_K2117004 encodes the humanized Renilla reniformis green fluorescent protein (hrGFP) codon-optimized for Yarrowia lipolytica and the translation elongation factor-1α (TEF1) promoter. We have used this device to demonstrate heterologous protein expression in Y. lipolytica and experimentally validated it through confocal laser scanning microscope.

Collaboration

We have helped different iGEM teams during summer: Uppsala iGEM, UNIK-cph, SDU-Denmark. For more information please see collaborations.

Human Practices

We sure went beyond the lab bench during this project. Our biggest achievement was the launch of the Biosensor project, a platform for allowing over 200 high schools nationwide. We also held meet-ups for other iGEM teams, presented our project at different events and got media coverage. Please see our practices page for elaboration.

Gold

Integrated Human Practices

Throughout our project we have been in close contact and collaboration with the industry. We started out searching for abundant waste streams in Denmark by contacting and visiting local factories, then we presented our idea to biotech manufacturing companies and all together the feedback made us more aware of the challenges our technology is facing and it ultimately led us to a more feasible product. Please see (link)

Improve a previous part

We have improved the two BioBricks; BBa_K530001 (CrtE gene) and BBa_K530002 (CrtI gene) created by the John Hopkins iGEM team 2011. We used site directed mutagenesis to successfully remove of two illegal restriction sites and further improved the characterization. Please see the parts page for elaboration.

Proof of concept

We successfully designed a functional plasmid (pSBB1A8YL) for transformation and replication in both E. coli and Y. lipolytica. pSBB1A8YL is also compatible with the BioBrick standard by assembly with our own BioBrick device BBa_K2117005. Further we showed that we could utilize the construct in Y. lipolytica to express a heterologous protein, hrGFP. Please see the proof of concept page for elaboration.

Demonstrate your work

Section 3

Has ut facer debitis, quo eu agam purto. In eum justo aeterno. Sea ut atqui efficiantur, mandamus deseruisse at est, erat natum cum eu. Quot numquam in vel. Salutatus euripidis moderatius qui ex, eu tempor volumus vituperatoribus has, ius ea ullum facer corrumpit.

Section 4

Has ut facer debitis, quo eu agam purto. In eum justo aeterno. Sea ut atqui efficiantur, mandamus deseruisse at est, erat natum cum eu. Quot numquam in vel. Salutatus euripidis moderatius qui ex, eu tempor volumus vituperatoribus has, ius ea ullum facer corrumpit.

Section 5

Has ut facer debitis, quo eu agam purto. In eum justo aeterno. Sea ut atqui efficiantur, mandamus deseruisse at est, erat natum cum eu. Quot numquam in vel. Salutatus euripidis moderatius qui ex, eu tempor volumus vituperatoribus has, ius ea ullum facer corrumpit.

Section 6

Has ut facer debitis, quo eu agam purto. In eum justo aeterno. Sea ut atqui efficiantur, mandamus deseruisse at est, erat natum cum eu. Quot numquam in vel. Salutatus euripidis moderatius qui ex, eu tempor volumus vituperatoribus has, ius ea ullum facer corrumpit.

Section 7

Has ut facer debitis, quo eu agam purto. In eum justo aeterno. Sea ut atqui efficiantur, mandamus deseruisse at est, erat natum cum eu. Quot numquam in vel. Salutatus euripidis moderatius qui ex, eu tempor volumus vituperatoribus has, ius ea ullum facer corrumpit.

  • FIND US AT:
Facebook Twitter
  • DTU BIOBUILDERS
  • DENMARK
  • DTU - SØLTOFTS PLADS, BYGN. 221/002
  • 2800 KGS. LYNGBY

  • E-mail:
  • dtu-biobuilders-2016@googlegroups.com
  • MAIN SPONSORS:
Lundbeck fundation DTU blue dot Lundbeck fundation Lundbeck fundation